Formation and spectroscopic characterization of the dioxygen adduct of a heme–Cu complex possessing a cross-linked tyrosine–histidine mimic: modeling the active site of cytochrome c oxidase

Jin-Gang Liu , Yoshinori Naruta *, Fumito Tani , Takefumi Chishiro and Yoshimitsu Tachi
Institute for Materials Chemistry and Engineering, Kyushu University, Higashi-ku, Fukuoka 812-8581, Japan. E-mail: naruta@ms.ifoc.kyushu-u.ac.jp; Fax: +81-(0)92-642-2715; Tel: +81-(0)92-642-2731

Received (in Cambridge, UK) 19th September 2003 , Accepted 21st October 2003

First published on 24th November 2003


Abstract

A binucleating porphyrin with covalently appended copper chelates having a cross-linked imidazole–phenol group as the novel active site model of cytochrome c oxidase has been prepared, and the dioxygen adduct of its iron(II)–copper(I) complex was spectroscopically characterized.


Cytochrome c oxidase (CcO), the terminal enzyme of the respiratory chain, catalyzes the 4e/4H+ reduction of dioxygen to water without generating toxic reactive intermediates, conserving the released energy for the synthesis of ATP.1 The active site of O2 reduction is comprised of heme a3/CuB binuclear moiety in which one of the copper-bound histidines is covalently cross-linked to a tyrosine residue between the C6 of Tyr244 and the ε-nitrogen of His 240 (in the bovine enzyme sequence).2 This unprecedented Tyr-His cross-link is proposed either to function as an electron and a proton donor to the dioxygen bound to heme a3 or to fix CuB in a certain configuration and distance from heme a3 during the catalytic O2 reduction.3 A number of heme-based dinuclear Fe–Cu complexes have been reported as model compounds in the hope of unraveling the mechanism of O2 reduction in the active site of CcO.4 However, the reported heme-based models are devoid of the Tyr-His cross-linkage. There are a few recent reports5 about the syntheses and physicochemical investigations of cross-linked phenolimidazoles. Very recently, Karlin and co-workers6 reported copper complexes with imidazole–phenol cross-links as an initial synthetic model for the CuB site in CcO. Herein we report the first example of constructing a heme-containing model with covalently appended copper chelates having a cross-linked imidazole–phenol group as a novel CcO model compound.

The synthetic routes to the desired compounds are shown in Scheme 1. The aldehyde 3 is prepared firstly from the coupling of methoxymethyl (MOM)-protected 2-hydroxyphenylboronic acid (1) with 4(5)-(tert-butyldiphenylsilanyloxymethyl)-1H-imidazole (2),7 followed by removing the silyl protecting group and then oxidized by activated MnO2. It is noteworthy that none of the desired product is obtained when 1H-imidazole-4-carbaldehyde is employed for the coupling. The MOM-protected phenylboronic acid (1) can be obtained in 65% overall yield by sequential reactions involving metalation (n-BuLi/ether/−70 °C) of MOM-protected 2-bromo-4-methylphenol, and treatment with B(OMe)3, followed by acidic work-up. Treatment of 3 with 2-aminomethylimidazole in methanol generates the corresponding Schiff base intermediate, which is consequently reduced by NaBH4in situ to give 4 in a yield of 65%. The tripodal ligand 5 is isolated by reacting the amine 4 with methyl 6-chloromethylnicotinate in the presence of K2CO3 in CH3CN, and then hydrolyzing in a KOH solution. The prepared tripodal ligand is an important building block in assembling CcO active site models. The condensation reaction between 5 and the porphyrin 6 (2-[10,15,20-tris-(2,4,6-trimethyl-phenyl)-porphyrin-5-yl]-phenylamine) is performed in the presence of Et3N/2-chloromethylpyridinium iodide in CH2Cl2 to give the covalent conjugate LOMOM (7) in 63% yield. Finally, the MOM group is removed with bromotrimethylsilane in CH2Cl2 at − 30 °C to regenerate the phenolic hydroxyl group and the hydroxyl free ligand LOH (8) is obtained in a moderate yield (60%).



          Reagents and conditions:
					(i) cat. [Cu(OH)TMEDA]2Cl2, CH2Cl2, O2, rt, 75%; (ii)
					n-BuN+F−, THF, rt, 93%; (iii) MnO2, CHCl3, reflux, 85%; (iv)
					a, 2-aminomethylimidazole, Et3N, MeOH, b, NaBH4, 65%; (v) methyl 6-chloromethylnicotinate, K2CO3, CH3CN, rt, 61%; (vi) KOH, THF, rt, 86%; (vii) 2-chloromethylpyridinium iodide, 5, Et3N, CH2Cl2, rt, 63%; (viii) Me3SiBr, CH2Cl2, − 30 °C, 60%.
Scheme 1 Reagents and conditions: (i) cat. [Cu(OH)TMEDA]2Cl2, CH2Cl2, O2, rt, 75%; (ii) n-BuN+F, THF, rt, 93%; (iii) MnO2, CHCl3, reflux, 85%; (iv) a, 2-aminomethylimidazole, Et3N, MeOH, b, NaBH4, 65%; (v) methyl 6-chloromethylnicotinate, K2CO3, CH3CN, rt, 61%; (vi) KOH, THF, rt, 86%; (vii) 2-chloromethylpyridinium iodide, 5, Et3N, CH2Cl2, rt, 63%; (viii) Me3SiBr, CH2Cl2, − 30 °C, 60%.

Stepwise metalation of the porphyrins, 7 and 8, begins with addition of excess FeBr2 in THF at reflux, followed by extraction with an aqueous Na2EDTA solution, yielding the corresponding mononuclear FeII porphyrins, LOMOMFeII and LOHFeII, respectively. Addition of copper salt [Cu(CH3CN)4]+ CF3SO3 gives the desired FeII/CuI complexes with similar UV–vis spectra to those of their mononuclear FeII complexes, [LOMOMFeIICuI]+ (9), ESI–MS m/z = 1330.5 (M+); [LOHFeIICuI]+ (10), ESI–MS m/z = 1286.5 (M+).

Both 9 and 10 react with O2 at − 30 °C in CH3CN to give the dioxygen adducts [LOMOMFeIII–O2–CuII]+ (11) and [LOHFeIII–O2–CuII]+ (12), respectively. The formation of the corresponding peroxo species was evidenced by the following observations: (1) upon exposure of the reduced form 9 or 10 to O2, its UV–vis spectra show distinctive changes with clear isosbestic points. The Soret band shifts from 429 nm to 421 nm, and the Q-band at 533 nm disappears (Fig. 1), which indicates the formation of a dioxygen adduct as described for those of our previously isolated peroxo-bridged Fe–O2–Cu species.8 (2) ESI mass spectra of the dioxygen adducts show a distribution of peaks centered at 1362.5 (M+) for 11, and 1318.5 (M+) for 12. The observed isotope distribution of peaks agrees very well with the simulated pattern based on the ratio of FeII–CuI : O2 = 1 : 1. The expected increase in mass of 4 is observed when 11 (m/z, M+, 1366.5) or 12 (m/z, M+, 1322.5) forms from 18O2. (3) The resonance Raman spectra of 11 shows an isotope dependent peak at 801 cm−1 which shifts to 755 cm−1 with 18O-labeled dioxygen, and 12 displays a similar isotope sensitive band at 799 (16O2) and 752 cm−1 (18O2), respectively (Fig. 2). The observed isotopic shifts are in good agreement with the value calculated from the harmonic oscillator approximation of the O–O stretching vibration [Δcalcd(16O2/18O2) = 46 cm−1]. These observed ν(O–O) values are similar to those of previous reported dioxygen adducts in the peroxy state.4,8 (4) Both 11 and 12 are EPR silent in a frozen solution (CH3CN, 77K), which indicates the presence of the strong antiferromagnetic coupling between the two metals.


UV–visible spectral changes of 10, [LOHFeIICuI]+, to 12 upon exposure to dioxygen in CH3CN at −30 °C.
Fig. 1 UV–visible spectral changes of 10, [LOHFeIICuI]+, to 12 upon exposure to dioxygen in CH3CN at −30 °C.

Resonance Raman spectra of 12 formed from 16O2
					(A) and 18O2
					(B). The difference spectra A minus B is shown as trace C (3% toluene in CH3CN, −30 °C, 413 nm excitation).
Fig. 2 Resonance Raman spectra of 12 formed from 16O2 (A) and 18O2 (B). The difference spectra A minus B is shown as trace C (3% toluene in CH3CN, −30 °C, 413 nm excitation).

The formed peroxo species are stable at − 30 °C in CH3CN, and on warming of the solution to room temperature (after removal of excess O2in vacuo), the dioxygen adducts [LOMOMFeIII–O2–CuII]+ (11) and [LOHFeIII–O2–CuII]+ (12) exhibit interesting differences. For 11, the major decomposed product is the μ-oxo complex formulated as [LOMOMFeIII–O–CuII]+ [m/z, 1346.6 (M+)] with UV–vis features [λmax = 440 nm (Soret)] similar to the reported μ-oxo analogues.8,9 By contrast, no μ-oxo final species is observed for 12. The final decomposed product demonstrates features like that of the hydroxo ferric porphyrin derivatives.10 The EPR spectrum (MeCN, 77 K) of the product shows signals at g = 5.56 and 1.99 corresponding to a high spin iron(III) porphyrin, and signals at g = 2.23 and g = 2.06, which are assigned to a S = 1/2 Cu(II) ion in a tetragonal field.11 We tentatively formulate the product as [LOHFeIII–OH, CuII]2+. The decomposition mechanism and further product characterization are in progress.

In summary, a novel heme-based binucleating ligand incorporated with N-(2′-hydroxyphenyl)imidazole moiety as a CcO's CuB site mimic has been designed and successfully prepared. The oxygenation reaction with its iron(II)–copper(I) complex has been preliminarily investigated by various spectroscopic methods.

This work was financially supported by the Grant-in-Aid for COE Research (#08CE2005) and for Scientific Research on Priority Areas (#09235225 and 11228207) from MEXT and for Scientific Research (A) (#14204073) from JSPS. P&P project, Green Chemistry, of Kyushu University partly supported this research. J.-G. Liu gratefully acknowledges JSPS for providing postdoctoral fellowship.

Notes and references

  1. S. Ferguson-Miller and G. T. Babcock, Chem. Rev., 1996, 96, 2889 CrossRef CAS; G. T. Babcock, Proc. Natl. Acad. Sci. USA, 1999, 96, 12971 CrossRef CAS.
  2. S. Yoshikawa, K. Shinzawa-Itoh, R. Nakashima, R. Yaono, E. Yamashita, N. Inoue, M. Yao, M. J. Fei, C. P. Libeu, T. Mizushima, H. Yamaguchi, T. Tomizaki and T. Tsukihara, Science, 1998, 280, 1723 CrossRef CAS; C. Ostermeier, A. Harrenga, U. Ermler and H. Michel, Proc. Natl. Acad. Sci. USA, 1997, 94, 10547 CrossRef CAS.
  3. D. A. Proshlyakov, M. A. Pressler, C. DeMaso, J. F. Leykam, D. L. DeWitt and G. T. Babcock, Science, 2000, 290, 1588 CrossRef CAS; E. Pinakoulaki, U. Pfitzner, B. Ludwig and C. Varotsis, J. Biol. Chem., 2002, 277, 13563 CrossRef CAS.
  4. J. P. Collman, R. Boulatov and C. J. Sunderland, in The Porphyrin Handbook, eds. K. M. Kadish, K. M. Smith and R. Guilard, Academic Press, San Diego, 2003, Vol. 11, pp. 1–49 Search PubMed and references cited therein..
  5. J. P. Collman, Z. Wang, M. Zhong and L. Zeng, J. Chem. Soc., Perkin Trans. 1, 2000, 1217 RSC; K. M. McCauley, J. M. Vrtis, J. Dupont and W. A. van der Donk, J. Am. Chem. Soc., 2000, 122, 2403 CrossRef CAS; J. A. Cappuccio, I. Ayala, G. I. Elliott, I. Szundi, J. Lewis, J. P. Konopelski, B. A. Barry and O. Einarsdottir, J. Am. Chem. Soc., 2002, 124, 1750 CrossRef CAS; M. Aki, T. Ogura, Y. Naruta, T. H. Le, T. Sato and T. Kitagawa, J. Phys. Chem. A, 2002, 106, 3436 CrossRef CAS.
  6. K. Kamaraj, E. Kim, B. Galliker, L. N. Zakharov, A. L. Rheingold, A. D. Zuberbuhler and K. D. Karlin, J. Am. Chem. Soc., 2003, 125, 6028 CrossRef CAS.
  7. J. P. Collman and M. Zhong, Org. Lett., 2000, 2, 1233 CrossRef CAS . The coupling reaction affords two isomers, N-1 and N-3 aryl products, which can be readily separated by silica-gel column chromatography in 75% (N-1) and 7% (N-3) yields, respectively..
  8. T. Chishiro, Y. Shimazaki, F. Tani, Y. Tachi, Y. Naruta, S. Karasawa, S. Hayami and Y. Maeda, Angew. Chem., Int. Ed., 2003, 42, 2788 CrossRef CAS; Y. Naruta, T. Sasaki, F. Tani, Y. Tachi, N. Kawato and N. Nakamura, J. Inorg. Biochem., 2001, 83, 239 CrossRef CAS.
  9. E. Kim, M. E. Helton, I. M. Wasser, K. D. Karlin, S. Lu, H.-W. Huang, P. Moenne-Loccoz, C. D. Incarvito, A. L. Rheingold, M. Honecker, S. Kaderli and A. D. Zuberbuhler, Proc. Natl. Acad. Sci. USA, 2003, 100, 3623 CrossRef CAS; M.-A. Kopf and K. D. Karlin, Inorg. Chem., 1999, 38, 4922 CrossRef CAS.
  10. Data for the decomposed product [LOHFeIII–OH, CuII]2+: UV–vis (CH3CN) λmax = 418, 560 nm. ESI–MS m/z = 651.9 (M2+)..
  11. F. Tani, Y. Matsumoto, Y. Tachi, T. Sasaki and Y. Naruta, Chem. Commun., 1998, 1731 RSC; B. Andrioletti, D. Richard and B. Boitrel, New J. Chem., 1999, 23, 1143 RSC . As comparison, the EPR spectrum of the dinuclear complex [LOHFeIII–CuII]OTf3 shows signals at g = 5.45 and 2.01, g = 2.24 and g = 2.09, respectively..

Footnotes

Electronic supplementary information (ESI) available: experiment procedures for preparing metal porphyrins and oxygenation reaction. See http://www.rsc.org/suppdata/cc/b3/b311538k/
Synthetic details will be reported elsewhere. All new compounds were fully characterized by spectroscopic methods. Stated yields refer to isolated compounds and the purity was guaranteed by chromatography. Data for LOH (8), 1H NMR (400 MHz, CDCl3) δ 8.84 (d, J = 8.0, 1 H), 8.75 (d, J = 4.8, 2 H), 8.67 (d, J = 4.4, 2 H), 8.63 (d, J = 3.6, 4 H), 8.03 (d, J = 6.0, 1 H), 7.85 (d, J = 7.2, 1 H), 7.83 (s, 1 H), 7.76 (s, 1 H), 7.54 (t, 1 H), 7.24 ∼ 7.26 (m, 6 H), 7.20 (s, 2 H), 7.14 (s, 1 H), 6.82 (d, J = 8.0, 1 H), 6.77 (d, J = 6.0, 1 H), 6.70 (d, J = 8.0, 1 H), 6.59 (d, J = 8.0 Hz, 1 H,), 6.28 (s, 1 H), 6.03 (s, 1 H), 3.29 (s, 2 H), 3.25 (s, 2 H), 3.16 (s, 2 H), 2.86 (s, 3 H), 2.60 (s, 3 H), 2.58 (s, 6 H), 2.13 (s, 3 H), 1.85 (s, 3 H), 1.82 (s, 6 H), 1.79 (s, 3 H), 1.75 (s, 6 H), − 2.54 (s, 2 H). IR (KBr) 3411, 3318, 3026, 2916, 2855, 1697, 1683, 1674, 1652, 1599, 1578, 1558, 1520, 1472, 1457, 1446, 1399, 1377, 1344, 1284, 1257, 1217, 1188, 1131, 1070, 968, 804 cm1. HR-MS (FAB, NBA) Found: 1170.5869. Calcd for C76H72N11O2: [M + H]+, 1170.5870.

This journal is © The Royal Society of Chemistry 2004
Click here to see how this site uses Cookies. View our privacy policy here.